Back to search

Impact of adjuvant therapy on quality of life in women with node-positive operable breast cancer

Data up to Jan 2025

Published1996
Citations175
References25

Total Citations Per Year

Abstract

References (25)

A Critical Appraisal of the Quality of Quality-of-Life Measurements

1994 • 2,068 citations

Quality of life and pharmacoeconomics in clinical trials

1996 • 1,796 citations

Systemic Treatment of Early Breast Cancer by Hormonal, Cytotoxic, or Immune Therapy:133 Randomised Trials involoving 31 000 Recurrences and 24 000 Deaths Among 75 000 Women (Summary)

1993 • 967 citations

Improving the Quality of Life during Chemotherapy for Advanced Breast Cancer

1987 • 548 citations

EVALUATION OF QUALITY OF LIFE IN PATIENTS RECEIVING TREATMENT FOR ADVANCED BREAST CANCER

1976 • 406 citations

A randomized trial of two dose levels of cyclophosphamide, methotrexate, and fluorouracil chemotherapy for patients with metastatic breast cancer.

1988 • 354 citations

Measuring quality of life in cancer patients.

1989 • 335 citations

Costs and benefits of adjuvant therapy in breast cancer: a quality-adjusted survival analysis.

1989 • 333 citations

Prognostic value of quality-of-life scores during chemotherapy for advanced breast cancer. Australian New Zealand Breast Cancer Trials Group.

1992 • 321 citations

Influence of physician communication on newly diagnosed breast patients' psychologic adjustment and decision-making

1994 • 291 citations

Psychosocial adjustment in women with breast cancer

1991 • 271 citations

Age differences in the psychosocial problems encountered by breast cancer patients.

1994 • 157 citations

On the receiving end—II. Linear analogue self-assessment (LASA) in evaluation of aspects of the quality of life of cancer patients receiving therapy

1983 • 156 citations

Measuring the quality of life of cancer patients: Psychometric properties of instruments

1988 • 117 citations

The Perceived Adjustment to Chronic Illness Scale (PACIS): a global indicator of coping for operable breast cancer patients in clinical trials

1993 • 97 citations

Responsiveness of a Single-Item Indicator Versus a Multi-Item Scale

1996 • 88 citations

Duration and reintroduction of adjuvant chemotherapy for node-positive premenopausal breast cancer patients.

1996 • 87 citations

On the receiving end — III Measurement of quality of life during cancer chemotherapy

1990 • 81 citations

Quality of life measures for patients receiving adjuvant therapy for breast cancer: an international trial

1992 • 81 citations

On the receiving end IV: Validation of quality of life indicators

1991 • 77 citations

Comparative trial of endocrine versus cytotoxic treatment in advanced breast cancer.

1977 • 62 citations

Feasibility of quality of life assessment in a randomized phase III trial of small cell lung cancer

1992 • 47 citations

Combination or mild single agent chemotherapy for advanced breast cancer? CMF vs epirubicin measuring quality of life

1993 • 43 citations

Psychosocial correlates of oestrogen and progesterone receptors in breast cancer

1990 • 31 citations

Timing of baseline quality of life assessment in an international adjuvant breast cancer trial: Its effect on patient self-estimation

1994 • 25 citations

Cited By (0)

No citing papers found in database

Impact of adjuvant therapy on quality of life in women with node-positive operable breast… (1996) – The Lancet | Metascience Observatory Explorer